Back to search

Article

Long-term Effectiveness of PCSK9 Inhibitors versus Ezetimibe as Adjunctive Therapy to Statins in Patients with Atherosclerotic Cardiovascular Disease: A TriNetX Database Analysis

2026-02-09

Abstract excerpt

<title>Abstract</title> <p>Purpose: Atherosclerotic cardiovascular disease (ASCVD) remains a leading cause of mortality. While statins are the cornerstone of therapy, many patients require intensification. This study compares the long-term real-world effectiveness of adding a proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor versus ezetimibe to background statin therapy. <h4>Methods:</h4> We conduc...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
be57d403-6598-58e0-b9ec-871dc6ad4554
DOI
10.21203/rs.3.rs-8606687/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Long-term Effectiveness of PCSK9 Inhibitors versus Ezetimibe as Adjunctive Therapy to Statins in Patients with Atherosclerotic Cardiovascular Disease: A TriNetX Database AnalysisDOI 10.21203/rs.3.rs-8606687/v1
Update on the use of PCSK9 inhibitors in adults: Recommendations from an Expert Panel of the National Lipid Association.Semantic proximity
Lipid-lowering and antihypertensive drugs on aortic disease risk: insights from Mendelian randomization analysis and real-world pharmacovigilance data.Semantic proximity
Using Healthcare Claims Data to Identify Health Disparities for Individuals with Diagnosed and Undiagnosed Familial HypercholesterolemiaSemantic proximity
PCSK9 (Proprotein convertase subtilisin/kexin type 9) inhibitors: past, present, and the future.Semantic proximity
Comparative Effectiveness of Second-line Antihyperglycemic Agents for Cardiovascular Outcomes: A Large-scale, Multinational, Federated Analysis of the LEGEND-T2DM StudySemantic proximity
Effect of Renin-Angiotensin System (RAS) Inhibitors in Acute Ischemic Stroke to Improve Outcomes in In-Patient Settings: A Cross Sectional and Longitudinal AnalysisSemantic proximity
Hospital mortality in COVID-19 patients in Belgium treated with statins, ACE inhibitors and/or ARBsSemantic proximity
Protective effects of statins on COVID-19 risk, severity and fatal outcome – a nationwide Swedish cohort studySemantic proximity
A phase III randomized trial evaluating alirocumab 300 mg every 4 weeks as monotherapy or add-on to statin: ODYSSEY CHOICE I.Semantic proximity
Analysis of Residual Risk and Recurrent Event Trends Following Acute Coronary Syndrome: A Cohort StudySemantic proximity
PCSK9 gene Polymorphism and Assessment of Cardiovascular Risk and Prognosis in Patients With Hyperlipidemia: A Retrospective Cohort Study.Semantic proximity
PCSK9 inhibition in myeloid cells enhances cardioprotection beyond its LDL cholesterol-lowering effectsSemantic proximity
Select a neighboring publication to make it the new centre.